Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

Benzinga Newsdesk www.benzinga.com Negative 92.9%

Neg 92.9% Neu 0% Pos 0%

Jefferies analyst Clara Dong downgrades Immunocore Holdings (NASDAQ:IMCR) from Buy to Hold and lowers the price target from $48 to $33.